MHRA invites current and former suppliers to join Risk Ledger and complete a security profile to strengthen supply chain cyber security.
Similar Posts
Guidance: MORE Submissions – user reference guide
A step-by-step guide on using the MORE Platform for Submissions of device related incidents.
Clinical trials for medicines: expert advice
Clinical trial applications that need expert advice from a specialist group or committee.
Guidance: MORE Registrations – user reference guide
A step-by-step guide on using the MORE Platform for Registrations for Submissions of device related incidents.
Valproate – reproductive risks
Information about the reproductive risks of taking valproate medicines and the measures in place to reduce potential harm.
Decentralised manufacture: UK Guideline on Good Manufacturing Practice (GMP)
UK guideline on GMP for decentralised manufacturing, ensuring compliance with EU GMP principles for safe, quality medicinal products.
Brensocatib licensed as the first medicine specifically designed to treat non-cystic fibrosis bronchiectasis in patients 12 years and older
As with any medicine, the MHRA will keep the safety and effectiveness of brensocatib under close review.